Heart Valve Devices | Market Insights | Europe (Supplemental) | 2021
The European market for heart valve devices will grow through 2029, fueled by an expanding aging population and rising adoption of THV devices, reflecting the accumulation of favorable clinical data for the use of these devices for patient populations usually treated with surgical devices. However, the COVID-19 global pandemic will have a significant impact on the European heart valve devices market, resulting in lost procedure volumes in the short term followed by a period of recovery.
This Medtech 360 Report provides high-level market metrics for heart valve devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.
